METTL3 and neoplasm: At the age of 9 months, compared with the control mice treated with DEN, DEN‐treated Mettl3 cKO mice displayed increased tumor nodules and aggravated changes in liver gross appearance, alongside increases in liver‐to‐body weight ratio and larger maximum surface tumor size (Fig. S3B–E).